Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind study of rupatadine fumarate capsules in seasonal allergic rhinitis
CTR20262455Phase 3Active
- Sponsor
- Lijiexun Pharmaceutical
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rupatadine in seasonal allergic rhinitis (SAR), sponsored by Lijiexun Pharmaceutical. Started Aug 2026; status: active.
02
Drugs
rupatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20262455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262455.